日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interpreting the biological effects of protons as a function of physical quantity: linear energy transfer or microdosimetric lineal energy spectrum?

将质子的生物效应解释为物理量的函数:线性能量转移还是微剂量线性能量谱?

Guan, Fada; Bronk, Lawrence; Kerr, Matthew; Li, Yuting; Braby, Leslie A; Sobieski, Mary; Wang, Xiaochun; Zhang, Xiaodong; Stephan, Clifford; Grosshans, David R; Mohan, Radhe

Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells

表观遗传复合物抑制靶向TP53突变型急性髓系白血病(AML)和AML干细胞/祖细胞

Carter, Bing Z; Mak, Po Yee; Muftuoglu, Muharrem; Tao, Wenjing; Ke, Baozhen; Pei, Jingqi; Bedoy, Andrea D; Ostermann, Lauren B; Nishida, Yuki; Isgandarova, Sevinj; Sobieski, Mary; Nguyen, Nghi; Powell, Reid T; Martinez-Moczygemba, Margarita; Stephan, Clifford; Basyal, Mahesh; Pemmaraju, Naveen; Boettcher, Steffen; Ebert, Benjamin L; Shpall, Elizabeth J; Wallner, Barbara; Morgan, Robert A; Karras, Georgios I; Moll, Ute M; Andreeff, Michael

Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer

XPO1 和 ATR 抑制剂的序贯给药可增强 TP53 突变型结直肠癌的治疗反应

Inoue, Akira; Robinson, Frederick S; Minelli, Rosalba; Tomihara, Hideo; Rizi, Bahar Salimian; Rose, Johnathon L; Kodama, Takahiro; Srinivasan, Sanjana; Harris, Angela L; Zuniga, Andy M; Mullinax, Robert A; Ma, Xiaoyan; Seth, Sahil; Daniele, Joseph R; Peoples, Michael D; Loponte, Sara; Akdemir, Kadir C; Khor, Tin Oo; Feng, Ningping; Roszik, Jason; Sobieski, Mary M; Brunell, David; Stephan, Clifford; Giuliani, Virginia; Deem, Angela K; Shingu, Takashi; Deribe, Yonathan Lissanu; Menter, David G; Heffernan, Timothy P; Viale, Andrea; Bristow, Christopher A; Kopetz, Scott; Draetta, Giulio F; Genovese, Giannicola; Carugo, Alessandro

Author Correction: Exploring the advantages of intensity-modulated proton therapy: experimental validation of biological effects using two different beam intensity-modulation patterns

作者更正:探索强度调制质子治疗的优势:使用两种不同束强度调制模式对生物效应进行实验验证

Ma, Duo; Bronk, Lawrence; Kerr, Matthew; Sobieski, Mary; Chen, Mei; Geng, Changran; Yiu, Joycelyn; Wang, Xiaochun; Sahoo, Narayan; Cao, Wenhua; Zhang, Xiaodong; Stephan, Clifford; Mohan, Radhe; Grosshans, David R; Guan, Fada

A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer.

高含量克隆形成存活药物筛选发现,MEK 抑制剂是 KRAS 突变型非小细胞肺癌的有效放射增敏剂

Lin Steven H, Zhang Jing, Giri Uma, Stephan Clifford, Sobieski Mary, Zhong Ling, Mason Kathy A, Molkentine Jessica, Thames Howard D, Yoo Stephen S, Heymach John V